The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 1,142,250 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
8X8 INC NEW | NOTE 0.500% 2/0 | 282914AB6 | 1,268,247 | 1,394,000 | PRN | SOLE | 1,394,000 | 0 | 0 | ||
AERCAP HOLDINGS NV | SHS | N00985106 | 4,217,250 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
ALIGHT INC | COM CL A | 01626W101 | 8,749,500 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
AMERICAN WTR WKS CO INC NEW | COM | 030420103 | 1,098,675 | 7,500 | SH | SOLE | 7,500 | 0 | 0 | ||
AN2 THERAPEUTICS INC | COM | 037326105 | 2,442,499 | 247,467 | SH | SOLE | 247,467 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 1,402,244 | 21,259 | SH | SOLE | 21,259 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 3,725,800 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
ATLAS ENERGY SOLUTIONS INC | COM CLASS A | 04930R107 | 3,406,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 2,519,000 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
AVALO THERAPEUTICS INC | COM NEW | 05338F207 | 105,000 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
BIOHAVEN LTD | COM | G1110E107 | 3,415,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
BIOMEA FUSION INC | COM | 09077A106 | 2,790,900 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
BUMBLE INC | COM CL A | 12047B105 | 2,443,750 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
CABLE ONE INC | NOTE 3/1 | 12685JAE5 | 2,373,960 | 3,000,000 | PRN | SOLE | 3,000,000 | 0 | 0 | ||
CACTUS INC | CL A | 127203107 | 1,133,825 | 27,500 | SH | SOLE | 27,500 | 0 | 0 | ||
CHART INDS INC | COM | 16115Q308 | 4,573,087 | 36,468 | SH | SOLE | 36,468 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757107 | 468,756 | 369,099 | SH | SOLE | 369,099 | 0 | 0 | ||
CLEARWATER ANALYTICS HLDGS I | CL A | 185123106 | 718,200 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
COMPASS THERAPEUTICS INC | COM | 20454B104 | 7,118,927 | 2,177,042 | SH | SOLE | 2,177,042 | 0 | 0 | ||
DOCUSIGN INC | NOTE 1/1 | 256163AD8 | 2,875,800 | 3,000,000 | PRN | SOLE | 3,000,000 | 0 | 0 | ||
EL POLLO LOCO HLDGS INC | COM | 268603107 | 713,496 | 74,400 | SH | SOLE | 74,400 | 0 | 0 | ||
ENGAGESMART INC | COMMON STOCK | 29283F103 | 2,021,250 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
ENLIGHT RENEWABLE ENERGY LTD | SHS | M4056D110 | 1,593,576 | 94,183 | SH | SOLE | 94,183 | 0 | 0 | ||
EVOLUS INC | COM | 30052C107 | 2,411,100 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | ||
GOLDMAN SACHS BDC INC | SHS | 38147U107 | 438,165 | 32,100 | SH | SOLE | 32,100 | 0 | 0 | ||
HERBALIFE NUTRITION LTD | NOTE 2.625% 3/1 | 42703MAD5 | 6,653,430 | 7,000,000 | PRN | SOLE | 7,000,000 | 0 | 0 | ||
ILLUMINA INC | NOTE 8/1 | 452327AK5 | 5,926,680 | 6,060,000 | PRN | SOLE | 6,060,000 | 0 | 0 | ||
INSMED INC | NOTE 1.750% 1/1 | 457669AA7 | 897,042 | 977,000 | PRN | SOLE | 977,000 | 0 | 0 | ||
INSMED INC | NOTE 0.750% 6/0 | 457669AB5 | 3,872,450 | 5,000,000 | PRN | SOLE | 5,000,000 | 0 | 0 | ||
INVESCO QQQ TR | UNIT SER 1 | 46090E103 | 18,293,010 | 57,000 | SH | SOLE | 57,000 | 0 | 0 | ||
ISHARES TR | RUSSELL 2000 ETF | 464287655 | 16,944,200 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 5,176,740 | 28,500 | SH | SOLE | 28,500 | 0 | 0 | ||
LAUREATE EDUCATION INC | COMMON STOCK | 518613203 | 2,438,118 | 207,323 | SH | SOLE | 207,323 | 0 | 0 | ||
LIVONGO HEALTH INC | NOTE 0.875% 6/0 | 539183AA1 | 8,886,600 | 10,000,000 | PRN | SOLE | 10,000,000 | 0 | 0 | ||
MINERALYS THERAPEUTICS INC | COM | 603170101 | 1,722,600 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
NEW RELIC INC | NOTE 0.500% 5/0 | 64829BAB6 | 7,962,960 | 8,000,000 | PRN | SOLE | 8,000,000 | 0 | 0 | ||
OKTA INC | NOTE 0.125% 9/0 | 679295AD7 | 5,018,261 | 5,567,000 | PRN | SOLE | 5,567,000 | 0 | 0 | ||
PG&E CORP | COM | 69331C108 | 808,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
RAIN ONCOLOGY INC | COM | 75082Q105 | 272,330 | 31,159 | SH | SOLE | 31,159 | 0 | 0 | ||
RAPID7 INC | NOTE 2.250% 5/0 | 753422AD6 | 1,908,313 | 1,855,000 | PRN | SOLE | 1,855,000 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 866,400 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
RINGCENTRAL INC | NOTE 3/0 | 76680RAF4 | 8,832,900 | 10,000,000 | PRN | SOLE | 10,000,000 | 0 | 0 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | 3,690,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ROYAL CARIBBEAN GROUP | COM | V7780T103 | 4,244,500 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
SOMALOGIC INC | CLASS A COM | 83444K105 | 2,524,146 | 989,861 | SH | SOLE | 989,861 | 0 | 0 | ||
SPLUNK INC | NOTE 0.500% 9/1 | 848637AC8 | 8,816,670 | 9,000,000 | PRN | SOLE | 9,000,000 | 0 | 0 | ||
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 4,044,300 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
SUPERNUS PHARMACEUTICALS | NOTE 0.625% 4/0 | 868459AD0 | 8,975,160 | 9,000,000 | PRN | SOLE | 9,000,000 | 0 | 0 | ||
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 12,038 | 120,382 | SH | SOLE | 120,382 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 1,686,750 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
VANGUARD INDEX FDS | TOTAL STK MKT | 922908769 | 156,136,500 | 765,000 | SH | SOLE | 765,000 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 4,995,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
WESTERN DIGITAL CORP. | NOTE 1.500% 2/0 | 958102AP0 | 2,695,569 | 2,789,000 | PRN | SOLE | 2,789,000 | 0 | 0 | ||
WIX COM LTD | NOTE 7/0 | 92940WAB5 | 2,753,580 | 2,789,000 | PRN | SOLE | 2,789,000 | 0 | 0 |